Benchmark Holdings has confirmed the major board changes that will take place when the company de-lists from the Oslo and London exchanges in August, including the appointment of a new CEO, Patrick Waty, who will take over from Trond Williksen.

Trond Williksen has been CEO of the Benchmark Group since 2020 and has had a distinguished career in business, including spells as CEO at salmon giant SalMar and aquaculture technology business Akva.
Patrick Waty is currently CEO of INVE Aquaculture, an aquafeed and feed technology business within the Benchmark Group. He has worked in several aquaculture businesses in Belgium and France.
The other board changes include Pierre Hugo coming in as Chief Financial Officer, succeeding Septima Maguire who stepped down from her role as Chief Financial Officer on 30 June 2025, as well as several changes in the non-executive director line-up:
As previously announced, Nathan "Tripp" Lane, Chairman of the company, will also step down when Benchmark completes its two de-listings, on 15 and 30 August.
Patrick Waty and Pierre Hugo will not become directors of the company.
In March this year, Benchmark Holdings sold its breeding and genetics arm, Benchmark Genetics, to Novo Holdings, the holding company for Danish pharmaceutical giant Novo Nordisk. Benchmark retained its animal health and nutrition businesses.
In May, Benchmark Holdings announced it would be de-listing its shares – so they will no longer be traded on the London and Oslo stock exchanges – and returning the proceeds from the sale of Benchmark Genetics to its shareholders, through a special dividend and buy-back scheme.
The company’s three leading shareholders – Ferd AS, the Witzøe family’s investment vehicle Kverva and London investor JNE Partners – did not take part in the buy-back scheme, and will now effectively take control of Benchmark Holdings.

Why not try these links to see what our Fish Farmer AI can tell you.
(Please note this is an experimental service)